Dr. Moore Honored with NYAM Award
February 16, 2011
Anne Moore, MD, Professor of Clinical Medicine and Medical Director of the Weill Cornell Breast Center, will be honored by The New York Academy of Medicine with the 2011 Academy Plaque for Exceptional Service to the Academy. Dr. Moore, a member of Weill Cornell's Division of Hematology and Medical Oncology for 35 years, specializes in the research and treatment of breast cancer. The Academy Plaque, one of the academy's most prestigious awards, will be presented to Dr. Moore at a special ceremony in New York City November 9, 2011.
When Dr. Moore first set her sights on breast cancer, in the early 1970s, there were few female physicians treating the disease. After earning her MD in 1969 at the Columbia University College of Physicians and Surgeons and serving her residency at New York Hospital, she completed a research fellowship in the laboratory of Henry G. Kunkel at The Rockefeller University and a hematology/oncology fellowship with Ralph L. Nachman at Weill Cornell. She joined the Weill Cornell faculty as Assistant Professor of Medicine in 1975, was promoted to Professor of Clinical Medicine in 1996 and became Medical Director of the Breast Oncology Program in 2007. An early advocate of an individualized approach to cancer treatment, Dr. Moore started a weekly multidisciplinary breast cancer conference with her colleagues in 1990 to consider every aspect of a patient's case and deliver tailored treatment solutions.
"It is a great honor to be selected by The New York Academy of Medicine for this award. Dr Jeremiah Barondess introduced me to the institution when he left Weill Cornell to become President. It was very exciting to serve on the board during his tenure. We saw the academy define itself as a leader in the field of urban health. I was nominated to the New York Community Trust Board by the academy. The Trust shares the vision of the academy, which Dr. Boufford has continued to expand: to make a difference to the millions of people living in the city. As a native New Yorker, I am grateful and proud to be part of this vision."
Dr. Moore is a Trustee of the New York Community Trust, a former Trustee of the American Board of Internal Medicine, past President of The New York Metropolitan Breast Cancer Group and former Chair of the NewYork-Presbyterian Hospital/Weill Cornell Medical Center Committee on Human Rights in Research. She has been included in New York magazine's "best doctors" lists every year, and her work has been recognized by Judges and Lawyers Breast Cancer Alliance, the Healthcare Chaplaincy and Susan G. Komen for the Cure. Most recently she was honored with the Cancer Research and Treatment Foundation's Lifetime Achievement Award. Dr. Moore's current clinical research includes breast cancer clinical trials and, as part of the Survivorship Program at the Breast Center, she collaborates in studies of side effects of medications commonly used in breast cancer.
Established in 1847, The New York Academy of Medicine is an independent organization that addresses the health challenges facing the world�s urban populations through interdisciplinary approaches to innovative research, education, community engagement and policy leadership. Drawing on the expertise of diverse partners worldwide and more than 2,000 elected Fellows from across the professions, the academy's current priorities are to create environments in cities that support healthy aging; to strengthen systems that prevent disease and promote the public's health; and to implement interventions that eliminate health disparities.